Teleflex (Teleflex) Net Margin %

: 4.02% (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Teleflex's Net Income for the three months ended in Dec. 2023 was $31 Mil. Teleflex's Revenue for the three months ended in Dec. 2023 was $774 Mil. Therefore, Teleflex's net margin for the quarter that ended in Dec. 2023 was 4.02%.

The historical rank and industry rank for Teleflex's Net Margin % or its related term are showing as below:

TFX' s Net Margin % Range Over the Past 10 Years
Min: 7.11 Med: 12.86 Max: 17.78
Current: 11.98

TFX's Net Margin % is ranked better than
76.53% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: 0.045 vs TFX: 11.98

Teleflex Net Margin % Historical Data

The historical data trend for Teleflex's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teleflex Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

17.78

13.22

17.28

13.01

11.98

Teleflex Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %																10.37	10.80	14.98	18.37	4.02

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Teleflex's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Teleflex Net Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Teleflex's Net Margin % distribution charts can be found below:

* The bar in red indicates where Teleflex's Net Margin % falls into.

Teleflex Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Teleflex's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	356.328	/	2974.489
	=	11.98 %

Teleflex's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	31.105	/	773.909
	=	4.02 %

Teleflex (NYSE:TFX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Teleflex Net Margin % Related Terms

Thank you for viewing the detailed overview of Teleflex's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Teleflex (Teleflex) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Teleflex Inc (NYSE:TFX) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

T1FX34:Brazil

Address

550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087

Website

https://www.teleflex.com

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2022 sales), interventional (16%), anesthesia (14%), surgical (14%), interventional urology (12%), original-equipment manufacturing (10%), and all other (10%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.

Executives

Liam Kelly	officer: EVP & President, International	IDA BUSINESS AND TECHNOLOGY PARK, DUBLIN ROAD, ATHLONE L2 00000
Thomas E Powell	officer: Senior Vice President & CFO	C/O TOMOTHERAPY INCORPORATED, 1240 DEMING WAY, MADISON WI 53717
Stuart A Randle	director	585 WEST 500 SOUTH, BOUNTIFUL UT 84010
Jaewon Ryu	director	950 N. GLEBE ROAD, SUITE 700, ARLINGTON VA 22203
Neena M Patil	director	JAZZ PHARMACEUTICALS, 3170 PORTER DRIVE, PALO ALTO CA 94304
Andrew A Krakauer	director	CANTEL MEDICAL CORP., 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Cameron P Hicks	officer: Vice President, Global HR	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Klasko Stephen K. M.d.	director	155 SOUTH LIMERICK ROAD, LIMERICK PA 19468
Jay White	officer: VP & Pres, Global Commercial	3015 CARRINGTON MILL BLVD., MORRISVILLE NC 27560
Daniel V. Logue	officer: VP, Gen Counsel & Secretary	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
John Deren	officer: VP & Chief Accounting Officer	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
James J Leyden	officer: VP, General Counsel, Secretary	C/O INFRASOURCE SERVICES, INC, 500 WEST DUTTON MILL ROAD, ASTON PA 19014
James Winters	officer: Vice President, Mfg and Supply	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Mario Wijker	officer: Vice President, QARA	550 E. SWEDESFORD ROAD, SUITE 400, WAYNE PA 19087
Benson Smith	director	C/O ROCHESTER MEDICAL INC, ONE ROCHESTER MEDICAL DDRIVE, STEWARTVILLE MN 55976